Table 4

Prognostic factors for relative survival
Factors N=(681) Number of deaths Univariate analysis Multivariate analysis (N=495)
RER 95% CI p value RER 95% CI p value
Age 681 0.001 0.18
75-79 310 107 1 1
80-84 208 88 0.99 0.52-1.88 1.01 0.47-2.16
≥85 163 110 2.75 1.68-4.48 2.15 1.02-4.55
pT stage 658 <0.001 0.04
pT0+pT1 283 91 0.53 0.24-1.17 1.77 0.72-4.36
pT2 245 109 1 1
Pt3+Pt4 130 89 3.89 2.20-6.82 2.58 1.23-5.42
pN stage 619 <0.001 0.14
pN0 350 132 1 1
pN+ 269 135 3.13 1.68-5.75 1.75 0.80-3.83
pM stage 640 <0.001 <0.001
pM0 576 227 1 1
pM1 64 47 10.18 6.11-16.95 6.86 3.43-13.73
Having a family doctor 672 <0.001 0.03
No 51 41 1 1
Yes 621 258 0.17 0.11-0.28 0.22 0.07-0.68
Histoprognostic SBR grade 642 <0.001 0.08
1+2 482 185 1 1
3 160 93 2.73 1.66-4.51 1.87 0.93-3.79
Hormone receptors 670 <0.001 0.006
Negative 80 46 1 1
Positive 590 255 0.38 0.23-0.63 0.33 0.16-0.70
Comorbidities 582 0.03 0.02
No 163 51 1 1
Yes 419 179 4.26 1.13-16.28 2.35 1.03-5.36
Diagnosis circumstances 580 0.10 0.13
Clinic 471 209 1 1
Individual screening 109 27 0.13 0.01-1.48 0.42 0.11-1.65
Place of residence 677 0.43
Rural 203 92 1
Urban 474 211 0.82 0.50-1.35
Period 681 0.79
1998-2003 321 190 1
2004-2008 360 115 1.07 0.66-1.73
Matrimonial status 471 0.89
Single* 288 131 1
Not single 183 73 0.96 0.53-1.75

Abbreviations: RER = relative excess rates; CI = confidence interval, N = number of patients.

* Patient single, divorced or widowed.

Dialla et al.

Dialla et al. BMC Cancer 2012 12:472   doi:10.1186/1471-2407-12-472

Open Data